Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sapacitabine

EU orphan designation number: EU/3/08/558   
Active ingredient: Sapacitabine
Indication: Treatment of acute myeloid leukaemia
Sponsor: Cyclacel Limited
Dundee Technopole, James Lindsay Place, Dundee DD1 5JJ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/07/2008 Centralised Orphan - Designation EMEA/OD/015/08 (2008)3657 of 10/07/2008